The importance of MSTN has been reported in several disease conditions, including cachexia, sarcopenia, muscular atrophy, and other muscular dystrophies such as Duchenne muscular dystrophy, and its inhibition is an important strategy for managing these disease conditions [16,17,18,19,20]. This evidence concerns the gene MSTN and muscular dystrophy.